Skip to content

Bruker BRKR Biospin — Goodwill

Similar metrics at other companies

WAT
WATBiosciences — Goodwill
$3.8B
Becton, Dickinson and Company logo
BDXBioPharma Systems — Goodwill
$96M
Labcorp Holdings logo
LHBiopharma Laboratory Services — Goodwill
$1.35B
Thermo Fisher Scientific logo
TMOLaboratory Products and Biopharma Services — Goodwill
$24.23B+1.9%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Goodwill
$4.44B+2.3%
Donaldson Company logo
DCILife Sciences Segment — Goodwill
$172.8M+2.2%

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bruker’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's biospin — goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's biospin — goodwill?
Bruker (BRKR) reported biospin — goodwill of $202.7M in Q4 2025.
How has Bruker's biospin — goodwill changed year-over-year?
Bruker's biospin — goodwill decreased by 8.4% year-over-year, from $221.2M to $202.7M.
What does biospin — goodwill mean?
Represents the total carrying value of goodwill allocated to the BioSpin operating segment. This asset reflects the premium paid over the fair value of net identifiable assets during business acquisitions within this specific scientific instrumentation division.